How to protect the heart in septic shock: A hypothesis on the pathophysiology and treatment of septic heart failure

Medical Hypotheses

Volumn 74, Issue 3, 2010, Pages 460-465

  Schmittinger, Christian A ^a   Wurzinger, Bettina ^b   Deutinger, Martina ^b   Wohlmuth, Christoph ^b   Knotzer, Hans ^a   Torgersen, Christian ^a   Dünser, Martin W ^c   Hasibeder, Walter R ^b  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b Krankenhaus der Barmherzigen Schwestern Ried Betriebsgesellschaft mbH   (Austria)

^c UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; CATECHOLAMINE; HYPERTENSIVE AGENT; INOTROPIC AGENT; LEVOSIMENDAN; REACTIVE OXYGEN METABOLITE;

ADRENERGIC SYSTEM; APOPTOSIS; ARTICLE; CARDIOTOXICITY; CATECHOLAMINE BLOOD LEVEL; CLINICAL FEATURE; FLUID RESUSCITATION; HEART FAILURE; HEART MUSCLE NECROSIS; HEART PROTECTION; HUMAN; INFLAMMATION; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; SEPTIC SHOCK; STUNNED HEART MUSCLE; SURVIVAL; TAKOTSUBO CARDIOMYOPATHY;

CARDIOTONIC AGENTS; CATECHOLAMINES; HEART FAILURE; HUMANS; MODELS, CARDIOVASCULAR; SHOCK, SEPTIC;

EID: 77649274390     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2009.10.012     Document Type: Article

References (55)

1. Annane D., Bellissant E., Cavaillon J.M. Septic shock. Lancet 2005, 365:63-78.
2. Krishnagopalan S., Kumar A., Parrillo J.E. Myocardial dysfunction in the patient with sepsis. Curr Opin Crit Care 2002, 8:376-388.
3. Bouhemad B., Nicolas-Robin A., Arbelot C., Arthaud M., Feger F., Rouby J.J. Isolated and reversible impairment of ventricular relaxation in patients with septic shock. Crit Care Med 2008, 36:766-774.
4. Vieillard-Baron A., Caille V., Charron C., Belliard G., Page B., Jardin F. Actual incidence of global left ventricular hypokinesia in adult septic shock. Crit Care Med 2008, 36:1701-1706.
5. Torgersen C., Moser P., Luckner G., et al. Macroscopic postmortem findings in 235 surgical intensive care patients with sepsis. Anesth Analg 2009, 108:1841-1847.
6. Rudiger A., Singer M. Mechanisms of sepsis-induced cardiac dysfunction. Crit Care Med 2007, 35:1599-1608.
7. Benedict C.R., Rose J.A. Arterial norepinephrine changes in patients with septic shock. Circ Shock 1992, 38:165-172.
8. Power I., Kam P. The autonomic nervous system. Principles of physiology for the anaesthetist 2001, Arnold, London. I. Power, P. Kam (Eds.).
9. Maxime V., Siami S., Annane D. Metabolism modulators in sepsis: the abnormal pituitary response. Crit Care Med 2007, 35(9 Suppl.):S596-S601.
10. Annane D., Bellissant E., Boallaert P.E., et al. Corticosteroids in the treatment of severe sepsis and septic shock in adults: a systematic review. JAMA 2009, 301:2362-2375.
11. Hollenberg S.M., Tangora J.J., Piotrowski M.J., et al. Impaired microvascular vasoconstrictive responses to vasopressin in septic rats. Crit Care Med 1997, 25:869-873.
12. Maxime V., Lesur O., Annane D. Adrenal insufficiency in septic shock. Clin Chest Med 2009, 30:17-27.
13. Jochberger S., Dörler J., Luckner G., et al. The vasopressin and copeptin response to infection, severe sepsis and septic shock. Crit Care Med 2009, 37:476-482.
14. Boldt J., Menges T., Kuhn D., Diridis C., Hempelmann G. Alterations in circulating vasoactive substances in the critically ill - a comparison between survivors and non-survivors. Intensive Care Med 1995, 31:218-225.
15. Annane D., Trabold F., Sharshar T., et al. Inappropriate sympathetic activation at onset of septic shock: a spectral analysis approach. Am J Respir Crit Care Med 1999, 160:458-465.
16. Benedict C.R., Grahame-Smith D.G. Plasma noradrenaline and adrenaline concentrations and dopamine-beta-hydroxylase activity in patients with shock due to septicaemia, trauma and haemorrhage. Q J Med 1978, 47:1-20.
17. Bernardin G., Strosberg A.D., Bernard A., Mattei M., Marullo S. Beta-adrenergic receptor-dependent and -independent stimulation of adenylate cyclase is impaired during severe sepsis in humans. Intensive Care Med 1998, 24:1315-1322.
18. Bocking J.K., Sibbald W.J., Holliday R.L., Scott S., Viidik T. Plasma catecholamine levels and pulmonary dysfunction in sepsis. Surg Gynecol Obstet 1979, 148:715-719.
19. Abboud I., Lerolle N., Urien S., et al. Pharmacokinetics of epinephrine in patients with septic shock: modelization, interaction with endogenous neurohormonal status. Crit Care 2009, 13:R120.
20. Kawai S., Suzuki H., Yamaguchi H., et al. Ampulla cardiomyopathy ('Takotsubo' cardiomyopathy) - reversible left ventricular dysfunction: with ST segment elevation. Jpn Circ J 2000, 64:156-159.
21. Dias V., Cabral S., Meireles A., et al. Stunned myocardium following ischemic stroke. Case report. Cardiology 2009, 113:287-290.
22. Lee V.H., Oh J.K., Mulvagh S.L., Wijdicks E.F. Mechanisms in neurogenic stress cardiomyopathy after aneurismal subarachnoid hemorrhage. Neurocrit Care 2006, 5:243-249.
23. Wittstein I.S., Thiemann D.R., Lima J.A., et al. Neurohumoral features of myocardial stunning due to sudden emotional stress. N Engl J Med 2005, 352:539-548.
24. Nanda A.S., Feldman A., Liang C.S. Acute reversal of pheochromocytoma-induced catecholamine cardiomyopathy. Clin Cardiol 1995, 18:421-423.
25. Macmillan C.S., Grant I.S., Andrews P.J. Pulmonary and cardiac sequelae of subarachnoid haemorrhage: time for active management?. Intensive Care Med 2002, 28:1012-1023.
26. Osuorji I., Williams C., Hessney J., Patel T., Hsi D. Acute stress cardiomyopathy following treatment of status asthmaticus. South Med J 2009, 102:301-303.
27. Park J.H., Kang S.J., Song J.K., et al. Left ventricular apical ballooning due to severe physical stress in patients admitted to the medical ICU. Chest 2005, 128:296-302.
28. Ellrodt A.G., Riedinger M.S., Kimchi A., Berman D.S., Maddahi J., Swan H.J., et al. Left ventricular performance in septic shock: reversible segmental and global abnormalities. Am Heart J 1985, 110:402-409.
29. Abraham J., Mudd J.O., Kapur N.K., Klein K., Champion H.C., Wittstein I.S. Stress cardiomyopathy after intravenous administration of catecholamines and beta-receptor agonists. J Am Coll Cardiol 2009, 53:1320-1325.
30. Margey R., Diamond P., McCann H., Sugrue D. Dobutamine stress echo-induced apical ballooning (Takotsubo) syndrome. Eur J Echocardiogr 2009, 10:395-399.
31. Silberbauer J., Hong P., Lloyd G.W. Takotsubo cardiomyopathy (left ventricular ballooning syndrome) induced during dobutamine stress echocardiography. Eur J Echocardiogr 2008, 9:136-138.
32. Taccone F.S., Lubicz B., Piagnerelli M., Van Nuffelen M., Vincent J.L., De Backer D. Cardiogenic shock with stunned myocardium during triple-H therapy treated with intra-aortic balloon pump counterpulsation. Neurocrit Care 2009, 10:76-82.
33. Prabhu S., Sharma V.N., Singh V. The effect of drugs on stress-induced changes of myocardial glycogen and blood glucose concentration in rats. Br J Pharmacol 1972, 44:814-816.
34. Raab W., Stark E., Macmillan W.H., Gigee W.R. Sympathogenic origin and antiadrenergic prevention of stress-induced myocardial lesions. Am J Cardiol 1961, 8:203-211.
35. Serra A.J., Higuchi M.L., Ihara S.S., et al. Exercise training prevents beta-adrenergic hyperactivity-induced myocardial hypertrophy and lesions. Eur J Heart Fail 2008, 10:534-539.
36. Burniston J.G., Ellison G.M., Clark W.A., Goldspink D.F., Tan L.B. Relative toxicity of cardiotonic agents: some induce more cardiac and skeletal myocyte apoptosis and necrosis in vivo than others. Cardiovasc Toxicol 2005, 5:355-364.
37. Tan L.B., Burniston J.G., Clark W.A., Ng Y., Goldspink D.F. Characterization of adrenoceptor involvement in skeletal and cardiac myotoxicity Induced by sympathomimetic agents: toward a new bioassay for beta-blockers. J Cardiovasc Pharmacol 2003, 41:518-525.
38. Mikaelian I., Coluccio D., Morgan K.T., et al. Temporal gene expression profiling indicates early up-regulation of interleukin-6 in isoproterenol-induced myocardial necrosis in rat. Toxicol Pathol 2008, 36:256-264.
39. Murray D.R., Prabhu S.D., Chandrasekar B. Chronic beta-adrenergic stimulation induces myocardial proinflammatory cytokine expression. Circulation 2000, 101:2338-2341.
40. Prabhu S.D., Chandrasekar B., Murray D.R., Freeman G.L. Beta-adrenergic blockade in developing heart failure: effects on myocardial inflammatory cytokines, nitric oxide, and remodeling. Circulation 2000, 101:2103-2109.
41. Bierhaus A., Humpert P.M., Nawroth P.P. Linking stress to inflammation. Anesthesiol Clin 2006, 24:325-340.
42. Barth E., Radermacher P., Thiemermann C., Weber S., Georgieff M., Albuszies G. Role of inducible nitric oxide synthase in the reduced responsiveness of the myocardium to catecholamines in a hyperdynamic, murine model of septic shock. Crit Care Med 2006, 34:307-313.
43. Hu A., Jiao X., Gao E., et al. Tonic beta-adrenergic drive provokes proinflammatory and proapoptotic changes in aging mouse heart. Rejuvenation Res 2008, 11:215-226.
44. Neri M., Cerretani D., Fiaschi A.I., et al. Correlation between cardiac oxidative stress and myocardial pathology due to acute and chronic norepinephrine administration in rats. J Cell Mol Med 2007, 11:156-170.
45. Parvin R., Akhter N. Protective effect of tomato against adrenaline-induced myocardial infarction in rats. Bangladesh Med Res Counc Bull 2008, 34:104-108.
46. Ellison G.M., Torella D., Karakikes I., et al. Acute beta-adrenergic overload produces myocyte damage through calcium leakage from the ryanodine receptor 2 but spares cardiac stem cells. J Biol Chem 2007, 282:11397-11409.
47. Linck B., Boknik P., Baba H.A., et al. Long-term beta adrenoceptor-mediated alteration in contractility and expression of phospholamban and sarcoplasmic reticulum Ca(++)-ATPase in mammalian ventricle. J Pharmacol Exp Ther 1998, 286:531-538.
48. Gustafsson A.B., Gottlieb R.A. Heart mitochondria: gates of life and death. Cardiovasc Res 2008, 77:334-343.
49. Karmazyn M., Moffat M.P. Role of Na+/H+ exchange in cardiac physiology and pathophysiology: mediation of myocardial reperfusion injury by the pH paradox. Cardiovasc Res 1993, 27:915-924.
50. Jaworski K., Sarkadi-Nagy E., Duncan R.E., Ahmadian M., Sul H.S. Regulation of triglyceride metabolism. IV. Hormonal regulation of lipolysis in adipose tissue. Am J Physiol Gastrointest Liver Physiol 2007, 293:G1-G4.
51. Mignen O., Shuttleworth T.J. I(ARC), a novel arachidonate-regulated, noncapacitative Ca(2+) entry channel. J Biol Chem 2000, 275:9114-9119.
52. Mignen O., Thompson J.L., Shuttleworth T.J. Ca2+ selectivity and fatty acid specificity of the noncapacitative, arachidonate-regulated Ca2+ (ARC) channels. J Biol Chem 2003, 278:10174-10181.
53. Ferrer R., Artigas A., Levy M.M., et al. Improvement in process of care and outcome after a multicenter severe sepsis educational program in Spain. JAMA 2008, 299:2294-2303.
54. Zanotti-Cavazzoni S.L., Guglielmi M., Parrillo J.E., Walker T., Dellinger R.P., Hollenberg S.M. Fluid resuscitation influences cardiovascular performance and mortality in a murine model of sepsis. Intensive Care Med 2009, 35:748-754.
55. Dünser M.W., Hasibeder W.R. Sympathetic overstimulation during critical illness: adverse effects of adrenergic stress. J Intensive Care Med 2009, 24:293-316.